Cleared Abbreviated

K022501 - INSTANT-VIEW MDMA (ECSTASY, XTC) URINE TEST (FDA 510(k) Clearance)

Nov 2002
Decision
107d
Days
Class 2
Risk

K022501 is an FDA 510(k) clearance for the INSTANT-VIEW MDMA (ECSTASY, XTC) URINE TEST. This device is classified as a Thin Layer Chromatography, Methamphetamine (Class II - Special Controls, product code DJC).

Submitted by Alfa Scientific Designs, Inc. (Poway, US). The FDA issued a Cleared decision on November 13, 2002, 107 days after receiving the submission on July 29, 2002.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3610.

Submission Details

510(k) Number K022501 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2002
Decision Date November 13, 2002
Days to Decision 107 days
Submission Type Abbreviated
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DJC — Thin Layer Chromatography, Methamphetamine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3610